Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001636282-25-000049
Filing Date
2025-05-08
Accepted
2025-05-08 16:01:12
Documents
83
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q syre-20250331.htm   iXBRL 10-Q 1370940
2 EX-31.2 spyre-20250331xex312.htm EX-31.2 9608
3 EX-32.1 spyre-20250331xex321.htm EX-32.1 6318
4 EX-31.1 spyre-2050331xex311.htm EX-31.1 9598
10 syre-20250331_g1.jpg GRAPHIC 367194
11 syre-20250331_g10.jpg GRAPHIC 132160
12 syre-20250331_g11.jpg GRAPHIC 588259
13 syre-20250331_g12.jpg GRAPHIC 282940
14 syre-20250331_g13.jpg GRAPHIC 72828
15 syre-20250331_g14.jpg GRAPHIC 70923
16 syre-20250331_g15.jpg GRAPHIC 72256
17 syre-20250331_g2.jpg GRAPHIC 70476
18 syre-20250331_g3.jpg GRAPHIC 82297
19 syre-20250331_g4.jpg GRAPHIC 262928
20 syre-20250331_g5.jpg GRAPHIC 155510
21 syre-20250331_g6.jpg GRAPHIC 77346
22 syre-20250331_g7.jpg GRAPHIC 91828
23 syre-20250331_g8.jpg GRAPHIC 57614
24 syre-20250331_g9.jpg GRAPHIC 58970
  Complete submission text file 0001636282-25-000049.txt   13147068

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT syre-20250331.xsd EX-101.SCH 49308
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT syre-20250331_cal.xml EX-101.CAL 57206
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT syre-20250331_def.xml EX-101.DEF 333696
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT syre-20250331_lab.xml EX-101.LAB 605642
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT syre-20250331_pre.xml EX-101.PRE 480793
86 EXTRACTED XBRL INSTANCE DOCUMENT syre-20250331_htm.xml XML 947476
Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Spyre Therapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37722 | Film No.: 25925806
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)